| FDA Allows Vytorin Labeling for Use in Kidney Disease - MedPage Today |
|
|
MedPage Today The FDA's Endocrinologic and Metabolic Drugs Advisory Committee also voted 10-6 against recommending approval for use of the drug in end-stage renal disease (ESRD) patients on dialysis. The new labeling announced by the FDA follows that recommendation |